NCT03816358 2026-05-13Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting74 enrolled